Biovica: Signs a resourceful Iberian (Spain and Portugal) partner for DiviTum - Redeye

The Palex group of 800 professionals with a long history as a leading provider of advanced solutions for healthcare professionals in hospitals, laboratories, and research. The for this collaboration is to make DiviTum available for more than 8,000 cases of metastatic breast cancer patients diagnosed each year in Spain and Portugal. The collaboration extends the European reach for DiviTum and the Iberian market is an interesting mix of public and private segments opening up for earlier reference user in our view.

Länk till analysen i sin helhet: https://www.redeye.se/research/971405/biovica-signs-a-resourceful-iberian-spain-and-portugal-partner-for-divitum?utm_source=finwire&utm_medium=RSS